ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Current Director Theo Melas-Kyriazi appointed Chairperson of the Board of Directors
August 10, 2021Kaleido Biosciences, Inc. (Nasdaq: KLDO) today announced the appointment of current Board member Theo Melas-Kyriazi as Chairperson of the Board of Directors effective August 9, 2021. -
Kaleido ends oversubscribed funding round at $101m
June 28, 2018Microbiome startup Kaleido Biosciences has closed its oversubscribed Series C financing round at $101m. Investment came from Fidelity Management, Invus, as well as a subsidiary of Abu Dhabi Investment Company and Flagship Pioneering, Kaleido’s founder.
Pharma Sources Insight January 2025
